Analysis of oxylipins derived from fatty acids may provide insight into the biological effects of dietary lipids beyond their effects on tissue fatty acid profiles. We have previously observed that diets with higher amounts of a-linolenic acid (ALA; 18:3n3) are associated with reduced obesity-related glomerulopathy (ORG). Therefore, to examine the renal oxylipin 
Introduction
Many of the functions of fatty acids in biological processes have been ascribed to oxylipins that are produced from fatty acids. Oxylipins are oxidized metabolites of fatty acids that can be formed attached to phospholipid or more commonly when fatty acids are released from membrane phospholipids via phospholipase A 2 , resulting in oxylipins such as the eicosanoids, octadecanoids, and docosanoids (1, 2) . Eicosanoids derived from arachidonic acid (ARA 8 ; 20:4n6) and EPA (20:5n3) have been the class of oxylipins most investigated; but recently, interest in docosanoids derived from DHA (22:6n3), including the resolvins, protectins, and maresins, has increased (3). However, little knowledge exists on octadecanoids derived from linoleic acid (LA; 18:2n6) and a-linolenic acid (ALA; 18:3n3), despite the fact that recent lipidomic analyses of human blood demonstrate that oxylipins derived from these fatty acids make up as much as two-thirds of the total oxylipin content (4) .
The most prevalent LA-derived oxylipins are the 9-and 13-hydroxyoctadecadienoic acids (HODEs). Although their roles in biology are much less understood than the eicosanoids, they have been shown to have a number of biological effects. These include antiinflammatory and antiproliferative effects (5-7) and influences on platelet reactivity (8, 9) and lipid efflux (10, 11) . HODEs and their metabolites, oxooctadecadienoic acids (oxoODEs), also appear to be produced nonenzymatically from LA under conditions of oxidative stress (12, 13) . In comparison, much less is known about the ALA oxylipins; there is only 1 report on the effect of hydroxyoctadecatrienoic acids (HOTrEs), suggesting that they have antiinflammatory properties in vitro (14) .
Dietary n6 and n3 PUFAs influence the production of oxylipins derived from ARA, EPA, and DHA (3, (15) (16) (17) , but how dietary LA and ALA manipulation affects the amounts of LA-and ALA-derived oxylipins has yet to be assessed. A recent study reported that LA oxylipins in human plasma were reduced when dietary LA was decreased (18) . But effects in other tissues, the influence of dietary ALA, or how dietary LA and ALA affect oxylipins formed directly from LA and ALA, as well as those formed from the longer-chain PUFAs derived from LA and ALA after desaturation/elongation, remain to be elucidated.
Dietary LA and ALA alter the fatty acid composition of tissue phospholipids (19) , so it is reasonable to expect that LA and ALA oxylipins would also be altered. However, whether the oxylipins produced from LA and ALA simply reflect tissue phospholipid fatty acid composition or whether they are formed from LA and ALA to the same extent as oxylipins from other fatty acids is not known. Preference of 18-carbon over 20-and 22-carbon fatty acids for lipoxygenase (LOX) and elongase enzymes has been demonstrated, suggesting that competition between substrate fatty acids is important (20, 21) . Knowledge of how fatty acid composition affects oxylipins will provide a better understanding of how dietary LA and ALA induce changes in tissue phospholipid fatty acid composition and how this relates to biological processes in health and disease associated with oxylipins.
The ability to alter the oxylipin profile through diet may be particularly important for obese individuals. Obesity may be associated with increased levels of proinflammatory and vasoconstrictive eicosanoids and decreased levels of antiinflammatory eicosanoids (22) . Oxidative stress, inflammation, and altered hemodynamics in kidneys of obese individuals are associated with the onset of an emerging condition referred to as obesity-related glomerulopathy (ORG) (23, 24) . The condition is characterized by hyperfiltration, glomerulomegaly, and, in the later stages, glomerulosclerosis, proteinuria, and renal insufficiency (25) . The findings reported in this article are part of a larger study that showed that glomerulomegaly in the diet-induced obese rat is a useful surrogate marker for the presence and severity of ORG. That study also revealed that higher dietary ALA was associated with a slower progression of ORG in this model of obesity. These outcomes will be reported in another publication that has been submitted for review (S. Caligiuri, T. Blydt-Hansen, K. Love, M. Gregoire, C. Taylor, P. Zahradka, H. Aukema, unpublished results). The purpose of the current analyses is to report the renal oxylipin lipidomic profile, to evaluate the potential of dietary LA and ALA levels and ratios to modulate this profile, to relate this profile to renal phospholipid fatty acid composition, and to examine whether oxylipins are associated with glomerulomegaly and disease progression in ORG.
Materials and Methods
Animals and diet. Male obese-prone Sprague-Dawley rats (Charles River Laboratories) at 9 wk of age were fed either a high-fat (HF) lard/ soy oil diet (280/29 g/kg diet, respectively; 55% of energy as fat) to induce obesity or a low-fat (LF; 25% of energy as fat) soy oil diet as a control for 12 wk. After this 12-wk feeding period, an LF soy oil and an HF lard/soy oil group were killed to serve as baseline controls. The remaining HF-fed rats were divided among 7 HF treatment diets with varying levels of ALA and LA for 8 wk, whereas an LF soy oil group was fed this diet throughout. At the end of the study, the rats weighed, on average, 643 6 47 g and did not differ in body weight. These rats exhibited increased visceral adiposity and minor renal pathologic changes, as evidenced by glomerulomegaly, scarce glomerulosclerosis, and mild proteinuria. Among diet groups, there were differences in mean glomerular volumes, but no differences in glomerulosclerosis, proteinuria, or serum creatinine. Further details are provided in a submitted manuscript that fully describes the renal pathology in this very early form of renal disease (S. Caligiuri, T. Blydt-Hansen, K. Love, M. Gregoire, C. Taylor, P. Zahradka, H. Aukema, unpublished results).
The dietary lipid in the HF treatment diets was composed of various oils to achieve divergent levels and ratios of LA and ALA, as indicated in Table 1 . Diets were formulated to achieve the nutrient intakes provided by the standard AIN-93G diet (26) but modified to achieve a macronutrient energy distribution of 30% carbohydrate, 15% protein, and 55% fat in the HF diets and 60% carbohydrate, 15% protein, and 25% fat in the LF diets. Diets indicated as oil/oil were a mixture of two oils as indicated in Table 1 .
Rats were killed via carbon dioxide asphyxiation, cervical dislocation, and trunk blood collection. The right kidneys were removed, frozen in liquid nitrogen, and stored at 280°C. Left kidneys were removed, bisected longitudinally across the hilum, and fixed in 10% formalin for 48 h, followed by short-term storage in PBS at 4°C before being embedded in paraffin wax and sectioned at 5 mm. All research procedures were performed in accordance with the Canadian Council for Animal Care guidelines and approved by the University of Manitoba Animal Care Committee.
Oxylipin analysis. Lyophilized whole kidney tissue was homogenized in TyrodeÕs salt solution (pH 7.6) in a 1:28 wt:v ratio and aliquoted with antioxidant cocktail [0.2 g/L BHT, 0.2 g/L EDTA, 2 g/L triphenylphosphine, and 2 g/L indomethacin in methanol:ethanol:water (2:1:1, v:v:v)] for subsequent oxylipin, fatty acid, and Western immunoblotting analyses. Samples for oxylipin analysis were prepared and analyzed by HPLC-MS/MS (Agilent 1100 API 2000) multiple-reaction monitoring using the method developed by Deems et al. (27) . Details of the deuterated internal standards, solvent gradient, mass transitions, and retention times for all deuterated standards and analytes, and detector response factors for analytes, are listed in Supplemental Tables 1-4 . Detection and quantification limits were set at 3 and 5 levels above the background, respectively. Quantification of oxylipins was determined by using the stable isotope dilution method (28) and expressed as nanograms per milligram of dry tissue.
Fatty acid analysis. Diet samples were homogenized in a 1:20 (wt:v) ratio of chloroform:methanol (2:1, v:v) with 0.01% BHT. Total diet and renal phospholipid fatty acids were analyzed, as described previously (29) . Values are expressed as nanograms per milligram of dry tissue with values <0.01 mg/mg dry tissue denoted as trace.
Western immunoblotting. Immunoblotting was performed as described previously (30) . For the detection of cyclooxygenase (COX)-1, 12/ 15-LOX, 15-LOX 2, and cytochrome P450 (CYP) 2c23, 14 mg of protein was applied to the gel for each sample. To detect COX-2, soluble epoxide hydrolase (sEH), and 5-LOX, 28 mg of protein was applied to the gel. Morphometric assessment of glomerular size. Tissue preparation and image collection were performed as described previously, with minor alterations (31) . Glomerular volume was determined with standard stereologic techniques developed by Weibel (32), as described previously (33) .
Data analysis. Statistical analyses were carried out by using SAS version 9.2 (SAS Institute). All data were tested for normality and homogeneity of variance by using Shapiro-Wilk and LeveneÕs test, respectively. To assess differences among age groups (baseline vs. endpoint) and different diets, all groups and all time points were analyzed by using ANOVA or KruskalWallis dependent on normality and followed by a post hoc test with either TukeyÕs Studentized range test (non-Gaussian data) or DuncanÕs multiple range test (Gaussian distribution). Correlation analyses were carried out by using SpearmanÕs correlation. All analyses were set at a significance level of P < 0.05. The data are presented as means 6 SEMs (n = 80 or n = 40 as indicated). To assess the relative ability of enzymes to convert different fatty acids to their respective oxylipins, values for each product: substrate ratio were grouped together for all diets and compared by 1-factor ANOVA followed by DuncanÕs multiple range test to compare differences across substrates, followed by a separate 1-factor ANOVA and DuncanÕs multiple range test to assess differences across dietary groups.
Results
Renal oxylipin profile. Of the 64 oxylipins scanned in this targeted lipidomic analysis, 30 oxylipins were present at detectable and quantifiable levels in the kidney. This included oxylipins derived from LA, dihomo-g-linolenic acid (DGLA; 20:3n6), ARA, ALA, EPA, and DHA (Tables 2 and 3). The oxylipins derived from LA were present in higher quantities than those derived from ARA, the most studied group of oxylipins. For example, among rats fed the LF and HF diets containing soy oil, which is the standard oil used in the AIN-93G diet (26) , LA oxylipins comprised ;58-61% of the total oxylipins that were examined, whereas those formed from ARA [prostanoids, hydroxyeicosatetraenoic acids (HETEs), and dihydroxyeicosatrienoic acids (DHETs)] contributed to ;31-35% of the total oxylipin profile. Those in smaller quantities included the DGLA metabolite 15-hydroxyeicosatrienoic acid (15-HETrE), which constituted ;0.25% of oxylipins; ALA oxylipins, which comprised 4-5%; and EPA and DHA oxylipins, which each comprised 1-2% of the total. Hence, LA and ALA oxylipins both constituted ;60% of the oxylipins derived from n6 and n3 PUFAs, respectively.
Dietary LA and ALA effects on renal oxylipins. Altering the LA or ALA content of the diets resulted in marked changes in the oxylipins derived directly from these fatty acids (Tables 2 and 3) . For example, when kidneys from rats fed the HF safflower oil diet with 73% LA were compared with kidneys from rats fed the HF lard/soy oil diet with 8% LA, HODE levels were 5-fold higher, and the HODE metabolite (oxoODE) levels followed a similar pattern and were 6-fold higher. In addition, levels of LA 1 Fatty acid data are analyzed values (n = 1/diet). Diets are ordered by the LF control first followed by the treatment diets, ranging from the highest to lowest ALA:LA ratios. BHT was purchased from Sigma-Aldrich. Capri canola oil, Capri vegetable (soy) oil, Nutra-Clear high-stability canola oil, and Jubilee Deep Fry Beef Fat (lard) were provided by Bunge Canada. Certified organic flax oil was purchased from Omega Nutrition. Refined high-linoleic safflower oil was purchased from Alnoroil Company. All other diet ingredients were purchased from Dyets. ALA, a-linolenic acid; HF, high-fat; LA, linoleic acid; LF, low-fat. 2 The mineral and vitamin mix compositions have been previously published (27) .
Dietary oil effects on oxylipins and fatty acids 1423 metabolites of the epoxygenase pathway (dihydroxyoctadecenoic acids) were almost 7-fold higher in kidneys of rats fed safflower compared with the lard/soy oil group. Similar differences in LA oxylipin levels were seen in comparisons between rats provided diets with less extreme differences in dietary LA and with similar ALA levels (i.e., HF soy oil vs. HF canola). In comparison to LA oxylipins, only some of those derived from ARA were altered by dietary LA, and only with extreme differences in dietary LA content. For example, levels of DHETs and HETEs were 77 and 33% higher, respectively, in kidneys from rats fed the HF safflower diet compared with those fed the HF lard/soy oil diet. In contrast, prostanoids derived from ARA were not altered by diet. For DGLA, 15-HETrE was higher when dietary LA was greater (HF safflower vs. HF soy oil; HF soy oil vs. HF high-oleic canola/canola).
Similar to LA effects, levels of the ALA metabolites were higher when more dietary ALA was provided in the diet. For example, renal HOTrE levels were 35-fold higher in rats provided the HF canola/flax with 20% ALA vs. the HF safflower with 0.2% ALA. Differences in ALA oxylipins also were observed between kidneys from rats given diets with less extreme differences in ALA content and similar levels of LA (i.e., HF canola/flax vs. HF high-oleic canola/canola).
Diets higher in ALA also positively influenced the production of EPA oxylipins. When kidneys from rats fed the HF canola/flax diet that contained 20% ALA were compared with those from rats fed the HF canola diet with 8% dietary ALA or the HF higholeic canola diet with 2% dietary ALA, hydroxyeicosapentaenoic acid (HEPE) levels were 1.6-and 7-fold higher, respectively. By comparison, the amount of DHA oxylipin [4-hydroxydocosahexaenoic acid (4-HDoHE)] was only different in the HF safflower group, which had extremely low ALA levels compared with the other diet groups, resulting in 4-HDoHE levels that were one-half to one-third those found in the other groups.
The effect of dietary LA and ALA levels on their respective oxylipins was not inhibited by higher dietary levels of the other fatty acid. For example, when comparing kidneys from the HF soy oil and HF canola diet groups, both ALA and the resulting renal HOTrE levels were similar, despite the level of dietary LA and renal HODE being ;2-fold higher in the HF soy oil group. In the reverse situation comparing HF canola/flax, HF canola, HF high-oleic canola/canola, and HF high-oleic canola dietary groups, the dietary levels of LA and the resulting renal HODE levels were similar, although the range of dietary ALA and renal HOTrE differed 4-fold among groups.
Effect of fat level and rat age on renal oxylipins. Altering the quantity of dietary fat, while keeping the proportion of dietary fatty acids the same, did not modify the oxylipin profile, as indicated by the lack of difference seen between the HF soy oil and LF soy oil groups (Tables 2 and 3 ). The oxylipin profile also did not change significantly with age; only 1 difference in a minor oxylipin (15-HETrE) was observed between the LF soy oil baseline and the LF soy oil endpoint group. No differences were noted between the HF lard/soy oil baseline and the HF lard/soy oil endpoint group.
Dietary LA and ALA effects on phospholipid fatty acids. Renal LA and ALA increased proportionally with dietary levels; however, much more LA than ALA accumulated in the renal phospholipids. This was observed in all diet groups but was most pronounced in the HF canola/flax group in which dietary levels of LA and ALA were similar, yet renal LA levels were ;18-fold higher ( Table 4) . With respect to their desaturase/elongase Values are means 6 SEMs (n = 8/dietary group). ''Trace'' was defined as ,0.0002 mg/mg dry tissue. Means without a common letter within each row differ, P , 0.05. ALA, a-linolenic acid; DHET, dihydroxyeicosatrienoic acid; DiHOME, dihydroxyoctadecenoic acid; HETE, hydroxyeicosatetraenoic acid; HETrE, hydroxyeicosatrienoic acid; HF, high-fat; HHTrE, hydroxyheptadecatrienoic acid; HODE, hydroxyoctadecadienoic acid; LA, linoleic acid; LF, low-fat; oxoODE, oxooctadecadienoic acid; PG, prostaglandin; TX, thromboxane.
Dietary oil effects on oxylipins and fatty acids 1425 products, dietary LA or ALA levels did not affect the renal levels of the n6 PUFAs DGLA and ARA. In contrast to these n6 PUFAs, renal EPA was higher in the dietary groups fed a higher ALA diet. In addition, EPA levels were influenced by dietary LA level. For example, despite similar levels of dietary ALA, renal EPA was higher in rats fed canola oil with 18% dietary LA compared with those fed soy oil with 53% LA. DHA also was altered by diet but to a lesser extent than EPA. DHA was significantly lower only in the safflower oil group, which had a very high LA and a very low ALA content.
Effect of enzyme levels and substrate preference on renal oxylipins. In addition to substrate fatty acid levels, oxylipin quantities could be influenced by the enzymes that catalyze their formation from their respective fatty acids. To examine whether enzyme levels were altered by diet, the protein levels of select enzymes involved in oxylipin formation (COX-1, COX-2, 5-LOX, 12/15-LOX, 15-LOX 2, sEH, CYP2c23) were assessed by immunoblotting. This analysis provided no evidence of differences in the protein levels of these enzymes among groups. However, due to the cross-reactivity of some of the antibodies, definitive conclusions could not be made in this regard.
To determine whether enzymes may have substrate preferences that would affect oxylipin formation, oxylipin:fatty acid substrate ratios were examined for 2 enzyme pathways for which a range of product:substrates was available. The precursors and respective products were as follows: 5-LOX and glutathione peroxidase convert ALA into 9-HOTrE (34), LA into 9-HODE (34), ARA into 5-HETE (35), EPA into 5-HEPE (36) , and DHA into 4-HDoHE (37); 15-LOX and glutathione peroxidase convert ALA into 13-HOTrE (38), LA into 13-HODE (38), ARA into 15-HETE (39), and DGLA into 15-HETrE (40) . Because the levels of these oxylipins generally increase with LOX activity, the combined activities will be referred to as 5-LOX and 15-LOX activities, respectively. These product to precursor ratios revealed that ALA and LA were converted to their respective metabolites more than the 20-carbon fatty acids, ALA was converted more than LA, and EPA more than ARA by the LOX enzymes (Fig. 1) . For 5-LOX, 9-HOTrE:ALA was ;1-fold higher than 5-HEPE:EPA, ;5-fold higher than 9-HODE:LA or 4-HDoHE:DHA, and ;15-fold higher than 5-HETE:ARA (Fig. 1) . For 15-LOX, 13-HOTrE: ALA was ;3-fold higher than 13-HODE:LA and ;12-fold higher than 15-HETrE:DGLA or 15-HETE:ARA (Fig. 2) .
Differences in product to precursor ratios were also observed between dietary groups. Higher HODE:LA was present in kidneys of rats in the HF safflower group compared with the other dietary groups as assessed by both 5-LOX and 15-LOX product:substrate ratios. In addition, 5-HEPE:EPA for 5-LOX was 1-and 2-fold higher in the HF soy oil groups compared with the HF high-oleic canola/canola and HF canola/flax groups (Fig. 1 ).
Oxylipins and renal pathology. Correlation analysis of renal oxylipins with mean glomerular volume was performed to examine potential relationships between oxylipins and glomerulomegaly, which is indicative of early ORG. This analysis revealed associations (all r = 20.3, P < 0.015) for only 4 oxylipins (9-and 13-HOTrE, 5-HEPE, and 4-HDoHE); notably, all 4 are derived from ALA, either directly or indirectly after desaturation/elongation to EPA and DHA. The scatterplots are available in Supplemental Figure 1 . All other oxylipins, including the LA-, ARA-, and DGLA-derived oxylipins, were not significantly correlated to glomerular size.
Discussion
Renal LA and ALA oxylipins each comprised ;60% of the oxylipins derived from n6 and n3 PUFAs, respectively, in kidneys from rats with ORG fed soy oil-based diets. This is consistent with reports of human plasma lipidomic analyses that have shown that LA and ALA oxylipins make up a large proportion of total oxylipins (4). Although the current and previous human plasma lipidomic analyses examined the most common 60 oxylipins, there are more that are present; hence, the absolute proportion may change as more metabolites are investigated. Nevertheless, the data herein demonstrate that the LA and ALA oxylipins are present at substantial levels and therefore may have important biological effects. Their roles in the kidney, as well as in other tissues, remains to be elucidated, because there is little information on the biological activity of these oxylipins, in contrast to the much larger literature available on the ARA, EPA, and DHA oxylipins. Of the available literature, it has been reported that LA oxylipins have antiinflammatory and antiproliferative effects in skin (6), inhibit leukotriene B 4 secretion from leukocytes (7), and inhibit tumor cell adhesion (5), whereas reports of HODE effects on platelet reactivity are contradictory (9) . HODE and oxoODE also have been implicated in oxidative stress and inflammation (41) . More recently, it has been shown that 13-HODE can induce cholesterol efflux from macrophages (9) and 9-oxoODE reduces TG content in mouse hepatocytes (11) . Dihydroxyoctadecenoic acids have been reported to induce chemotaxis in human neutrophils (42) , to have cytotoxic effects in renal proximal tubular cells (43) , and to be excreted in the urine (along with trihydroxyoctadeceonic acid) in response to salt loading (44) . Even less is known about ALA oxylipins. There is 1 report that the ALA oxylipin 13-HOTrE reduced interleukin (IL)-1b-induced expression of matrix metalloproteinase (MMP) 1, MMP-3, and MMP-9 in human chondrocytes, suggesting that 13-HOTrE may have a very influential role in physiologic processes (14) . Given their high prevalence in tissues, further studies on the biological effects of these oxylipins on various health and disease conditions are warranted.
The current analysis also demonstrated that the LA and ALA oxylipins can be significantly altered by dietary intervention. Diets providing greater levels of LA resulted in greater renal LA oxylipins and, in the case of very high levels of LA, the production of some DGLA and ARA oxylipins also were elevated. Likewise, the consumption of greater dietary ALA resulted in higher levels of ALA, EPA, and DHA oxylipins. Therefore, if specific oxylipins are shown to be beneficial or detrimental, the potential for dietary modulation to produce an optimal oxylipin profile exists in order to promote health. In this regard, correlation analyses revealed that glomerulomegaly in the diet-induced obese rat was inversely associated with renal oxylipins derived from ALA, either directly (9-and 13-HOTrE) or indirectly (5-HEPE, 4-HDoHE). This supports findings from the main study (S. Caligiuri, T. Blydt-Hansen, K. Love, M. Gregoire, C. Taylor, P. Zahradka, H. Aukema, unpublished results) that diets providing more ALA and higher ALA:LA ratios were inversely associated with mean glomerular volume, thus indicating renoprotection; by contrast, dietary and renal LA was not significantly associated with glomerulomegaly, and likewise, in the current study LA-derived oxylipins were not associated with glomerular size.
ORG is characterized by small increases in glomerular hydrostatic pressure, hyperfiltration (24) , and systemic inflammation, which create chronic mild inflammation within the glomerulus (23) . Some HEPEs and HDoHEs are precursors to Dietary oil effects on oxylipins and fatty acids 1427 the resolvins, which possess inflammation-resolving properties and therefore could contribute to renoprotection in this way (3) . To date, no data exist on the effects of HOTrEs, HEPE, or HDoHE on renal hemodynamics. One study has shown that 13-HOTrE suppressed the expression of MMP-1, MMP-3, and MMP-9 in chondrocytes (14) . These enzymes play a critical role in diabetic nephropathy, a renal disease that has similarities to ORG. In diabetic nephropathy, dysregulation of MMPs influences mesangial matrix expansion (45) and inhibition of MMPs early in Alport syndrome, a hereditary progressive renal disease, delays proteinuria and preserves glomerular integrity (46) . HOTrEs may therefore prevent the early progression of ORG via effects on MMPs.
Interestingly, prostanoids did not change across dietary groups and were not correlated to renal pathology. Higher levels of prostanoids are observed in kidneys with established disease compared with normal kidneys (30, 47) , which is likely due to their role in the innate immune response, induction of inflammation (17) , and effects on renal artery vasoconstriction and renal vascular resistance (48, 49) . The lack of correlation of prostanoids to pathology in the current study could be due to the fact that the model was in the early stages of ORG in which glomerulomegaly with mild renal damage present. Hence, ALA oxylipin changes may be earlier events in this form of renal injury.
Studies of dietary fatty acid effects on tissues are often interpreted on the basis of their effects on tissue fatty acid composition and their inferred effects on putative oxylipins produced. With the development of lipidomic methodology, these effects on oxylipins can be addressed directly. In the current study, comparison of renal phospholipid fatty acid composition and the oxylipin profile demonstrated that whereas fatty acid composition does reflect oxylipin content in general, there are important differences between the dietary effects on fatty acid composition compared with oxylipins. One such difference was the effect of dietary fatty acid on tissue fatty acid composition, with dietary LA being incorporated into renal phospholipid at much higher levels than with ALA. However, once in tissue, the formation of oxylipins from ALA was higher than the formation of oxylipins from LA, at least when estimated using indexes of 2 LOX enzymes. Interestingly, this pattern of preference for n3 over n6 fatty acids also was apparent for EPA over ARA. Similar findings have been reported for other enzymes involved in fatty acid metabolism, such as CYP450 and its preference for EPA and DHA over ARA (50) . In addition, the 18-carbon compared with longer-chain PUFAs were converted more to their respective oxylipins. Elongase and LOX enzymes also appear to prefer to metabolize C18 > C20 > C22 fatty acids (20, 21) . Hence, in addition to a high proportion of ALA undergoing b-oxidation (51), another reason why ALA does not accumulate in tissue phospholipid as much as LA could be due to the enhanced metabolism of ALA to oxylipins. It is also possible that this may be due to an exchange of oxylipins with blood oxylipins that are synthesized by other tissues. Further   FIGURE 1 Product to precursor ratios of 5-lipoxygenase products in diet-induced obese rats fed diets with varying levels of ALA and LA. Bars represent means 6 SEMs of HF endpoint groups (n = 4/diet group). Differing uppercase letters indicate differences in the enzyme selectivity of 5-lipoxygenase for substrates (P , 0.0001). Differing lowercase letters indicate differences between dietary groups in oxylipin production (P , 0.05). ALA, a-linolenic acid; ARA, arachidonic acid; HDOHE, hydroxydocosahexaenoic acid; HEPE, hydroxyeicosapentaenoic acid; HETE, hydroxyeicosatetraenoic acid; HODE, hydroxyoctadecadienoic acid; HOTrE, hydroxyoctadecatrienoic acid; LA, linoleic acid. FIGURE 2 Product to precursor ratios for 15-lipoxygenase products in diet-induced obese rats fed diets with varying levels of ALA and LA. Bars represent means 6 SEMs for all HF endpoint groups (n = 4/diet group). Differing uppercase letters indicate differences in the enzyme selectivity of 15-lipoxygenase for substrates (P , 0.0001). Differing lowercase letters indicate differences among dietary groups in oxylipin production (P , 0.001). ALA, a-linolenic acid; ARA, arachidonic acid; DGLA, dihomo-g-linolenic acid; HEPE, hydroxyeicosapentaenoic acid; HETE, hydroxyeicosatetraenoic acid; HETrE, hydroxyeicosatrienoic acid; HODE, hydroxyoctadecadienoic acid; HOTrE, hydroxyoctadecatrienoic acid; LA, linoleic acid.
comparison of product:substrate ratios for other oxylipinproducing enzymes and data from other tissues and plasma are needed to further explore the possible causes of these differences between renal fatty acid and oxylipin levels. In addition, the distribution of oxylipins relative to fatty acids within the kidneys needs to be evaluated, because the distribution of the enzymes that synthesize oxylipins differs significantly throughout the kidney (52, 53) .
Further evidence that the effects of dietary fatty acids on oxylipin formation are different than what would be suggested by their effects on tissue fatty acid composition was apparent in the kidneys from rats fed an HF canola/flax diet, which had similar levels of dietary LA and ALA. In these kidneys, LA was ;17.7-fold higher than ALA, but HODE was only 3.4-fold higher than HOTrE levels; in addition, ALA and EPA were present at similar levels in these kidneys, but the 5-LOX ALA metabolite (9-HOTrE) was 2-fold higher than the analogous EPA metabolite (5-HEPE). In addition, there were no differences in renal ARA content between any of the diet groups, but there were differences in DHET and HETE levels. Similarly, diet did not alter DGLA levels in the kidney, but 15-HETrE was higher with greater levels of dietary LA.
Another interesting disconnection between tissue fatty acid and oxylipin levels is that there appeared to be no competition for the formation of oxylipins from longer-chain n3 PUFAs by dietary LA. This is in contrast to evidence that higher levels of dietary LA compete with ALA, resulting in lower incorporation of n3 fatty acids in tissues (19) . For example, when comparing the HF canola and HF soy oil diets, which have similar levels of ALA, the levels of EPA in the kidneys from rats fed the HF soy oil diet were 36% lower than those from kidneys in the HF canola dietary group, reflecting the competition from the 3-fold higher LA level in the soy oil diet. On the other hand, HEPE levels in kidneys from rats fed the HF soy oil diet were not different from those in kidneys from rats fed the canola diet. Indeed, none of the other n3 fatty acid-derived oxylipin levels were different in kidneys from rats fed these 2 diets.
Dietary ALA, on the other hand, did not appear to compete with either the deposition of renal LA or its oxylipins. For example, when dietary LA levels were relatively similar and ALA was greater by 9-fold (HF canola/flax vs. HF high-oleic canola diet), there were no significant differences observed for renal LA or renal LA oxylipin levels between groups. This lack of competition of n6 oxylipins by dietary ALA is similar to a recent report in humans who consumed EPA and DHA ethyl ester supplements (900 mg total of n3 fatty acids), which increased plasma n3 oxylipins but did not decrease n6 oxylipins (15) . However, this may be tissue or species specific, because supplementation with ALA (54), EPA, or DHA (54,55) reduced synthesis of prostaglandin E 2 and thromboxane B 2 in human mononuclear cells ex vivo, and fish oil supplementation in normal mice reduced HETE levels in the colon (56) . Further studies with different ratios, various sources of PUFAs (e.g., ALA vs. EPA or DHA), different dietary fat levels, and analyses in other tissues are needed to explore this topic further.
In this study with diets varying in LA and ALA content, neither the level of fat nor age altered oxylipin levels in these rats. This may have been due to the relatively high level of dietary fat (25 vs. 55% of energy from fat) in LF compared with HF diets and the relatively small difference in age of the baseline rats compared with endpoint rats (21 vs. 29 wk of age). In previous studies of mice provided diets with varying n6:n3 fatty acid ratios and different levels of dietary fat in conjunction with an in vivo inflammatory stimulus, a higher level of dietary fat (20% of energy from fat) resulted in lower levels of peritoneal cell production of eicosanoids when compared with diets providing lower quantities of dietary fat (5% of energy from fat) (57) . In contrast to the current study, the source of n3 PUFAs was sardine oil, which is rich in EPA and DHA but has very little ALA.
In conclusion, the current study reported the renal oxylipin profile in the rat and showed that LA and ALA oxylipins are an important component of this profile. Furthermore, this profile was significantly altered by diets containing oils with varying levels of LA and ALA. Four oxylipins derived directly or indirectly from ALA were inversely correlated with glomerulomegaly, suggesting a possible protective effect of these unique oxylipins.
Comparison of the oxylipin profile with the renal phospholipid fatty acid profile showed that dietary effects on tissue fatty acid composition may not reflect the level of oxylipins. Dietary LA is incorporated into tissue at a much higher level than ALA, but renal ALA oxylipin/ALA is much higher than LA oxylipin/LA and EPA oxylipin/EPA for select LOX enzymes, suggesting that the impact of dietary ALA on oxylipins is greater than what is reflected by fatty acid composition. In contrast to renal phospholipid fatty acid composition, which is affected by both levels and ratios of dietary LA and ALA, the amount of dietary LA and ALA, but not the competition between these fatty acids, appears to determine oxylipin levels.
These findings have implications for dietary recommendations. For example, a recent systematic review concluded that there was no potential concern that eicosanoid levels would be altered with dietary LA, because plasma or erythrocyte phospholipid ARA content in humans was not altered by dietary LA if it was either increased by 6-fold or decreased by 90% (58) . The results of the current study show that LA and ALA oxylipins with potentially important biological effects are present in large amounts and are responsive to dietary intervention and that oxylipins (including eicosanoids) may be altered even when tissue fatty acid is not changed. Data on oxylipins, in addition to fatty acid data, are therefore warranted when examining dietary lipid effects on biology.
